First Tau PET Tracer Approved: Toward Accurate In Vivo Diagnosis of Alzheimer Disease-Reference-Cited by-同舟云学术

First Tau PET Tracer Approved: Toward Accurate In Vivo Diagnosis of Alzheimer Disease

Published:2020-10 Issue:10 Volume:61 Page:1409-1410
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Barthel Henryk

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging

Reference7 articles.

1. Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F-18]-T807

2. Fleisher AS Pontecorvo MJ Devous MD Sr . Positron emission tomography imaging with [18F]flortaucipir and postmortem assessment of Alzheimer disease neuropathologic changes. JAMA Neurol. April 26, 2020 [Epub ahead of print].

3. Brain tau imaging: Food and Drug Administration approval of 18F-flortaucipir injection;Mattay;J Nucl Med.,2020

4. Appropriate Use Criteria for Amyloid PET: A Report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer’s Association

5. Update on Appropriate Use Criteria for Amyloid PET Imaging: Dementia Experts, Mild Cognitive Impairment, and Education

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multimodal cross‐examination of progressive apraxia of speech by diffusion tensor imaging‐based tractography and Tau‐PET scans;Human Brain Mapping;2024-06

2. Early Diagnosis of Neurodegenerative Diseases: What Has Been Undertaken to Promote the Transition from PET to Fluorescence Tracers;Molecules;2024-02-04

3. Brain PET Imaging in Small Animals: Tracer Formulation, Data Acquisition, Image Reconstruction, and Data Analysis;Methods in Molecular Biology;2023-11-26

4. Relación entre aluminio y la enfermedad de Alzheimer: Revisión;Tecnura;2023-11-03

5. Tau-PET abnormality as a biomarker for Alzheimer’s disease staging and early detection: a topological perspective;Cerebral Cortex;2023-08-31